International Conference on Newborn Sequencing

Please click here to register

October 5-6, 2022,  2022 – Museum of Science, Boston, MA

GenomeWeb and The Precision Medicine Leaders’ Summit present the

International Conference on Newborn Sequencing

as part of our comprehensive coverage of the Precision Medicine Continuum

An in-person and livestreamed event

Doctors and scientists have long predicted that newborn sequencing would one day become a routine health check at birth, offering parents (and children) early guidance on how to plan for care that is tailored to the individual.
Learn how DNA sequencing is being implemented globally as a diagnostic and screening strategy for newborn children at the inaugural International Conference on Newborn Sequencing, to be held October 6, 2022, in Boston.
The Genomes2People Research Program has partnered with GenomeWeb’s Precision Medicine Leaders’ Summit to produce this event, which will be in-person and live streamed.
The International Conference on Newborn Sequencing will cover key issues surrounding the adoption of newborn sequencing to detect rare genetic diseases and other disorders in neonates, from technical considerations to operational challenges, ethical concerns, and the implications for long-term clinical care.
Rapid whole-genome sequencing is gaining acceptance as the quickest and most effective method to dramatically shorten the diagnostic odyssey for families of critically ill children. In addition, a number of efforts are underway to explore the feasibility of offering sequencing to all newborns to identify rare diseases within the first days of a baby’s life. These include the BabySeq Project, BeginNGS, GUARDIAN, Early Check, Screen Plus, Screen4Care in Europe, Baby Beyond in Australia and Genomics England’s Newborn Genomes Program in the UK.
Please join us to hear updates from the leaders of these programs as well as from other experts in the newborn sequencing community. This one day event will feature high-level discussions and ample networking opportunities with experts from national genomics programs, key research institutes, rare disease experts, and industry executives.
Topics of Discussion Include:
  • Updates on Cutting-Edge Newborn Genomics Studies
  • Technology Updates: New Methods and Workflows for Shortening the Diagnostic Odyssey
  • Ethical and Legal Considerations for Newborn Sequencing as a Screening Test
  • What is the Roadmap to Making Universal Newborn Sequencing a Reality?
  • Regulatory, Legislative, and Reimbursement Trends in Neonatal Sequencing
  • Parent and Family Perspectives on Newborn Sequencing
  • Gene Therapy as a Driver for Universal Newborn Sequencing
    plus many more….
Additional Information Here